Literature DB >> 25987803

Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia.

Aymeric Becq1, Violaine Ozenne1, Aurélie Plessier1, Patrice Valleur1, Xavier Dray1.   

Abstract

Gastric antral vascular ectasia (GAVE) may cause gastrointestinal bleeding (GIB). The treatment of GAVE relies on endoscopic approaches such as electrocoagulation (argon plasma coagulation, laser therapy, heater probe therapy, radiofrequency ablation), cryotherapy, and band ligation. In refractory cases, antrectomy may be considered. In the event of an associated cirrhosis and portal hypertension, it has been suggested that antrectomy could be an option, provided the mortality risk isn't considered too great. We report the case of a 67-year-old cirrhotic patient who presented with GAVE related GIB, unresponsive to multiple endoscopic treatments. The patient had a good liver function (model for end-stage disease 10). After a multidisciplinary meeting, a transjugular intrahepatic portosystemic shunt (TIPS) procedure was performed, in order to treat the cirrhosis associated ascites. The outcome was successful. An antrectomy was then performed, with no recurrence of GIB and no transfusion need during three months of follow up. In this case, the TIPS procedure achieved a complete ascites regression, allowing a safer surgical treatment of the GAVE-related GIB.

Entities:  

Keywords:  Antrectomy; Ascites; Cirrhosis; Gastric antral vascular ectasia; Gastrointestinal bleeding; Transjugular intrahepatic portosystemic shunt

Mesh:

Year:  2015        PMID: 25987803      PMCID: PMC4427702          DOI: 10.3748/wjg.v21.i18.5749

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

1.  The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

2.  Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension.

Authors:  L Spahr; J P Villeneuve; M P Dufresne; D Tassé; B Bui; B Willems; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

4.  Successful treatment of refractory gastric antral vascular ectasia by distal gastrectomy: a case report.

Authors:  Ting Jin; Bao-Ying Fei; Wei-Hua Zheng; Yong-Xiang Wang
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Treatment of watermelon stomach.

Authors:  Gareth S Dulai; Dennis M Jensen
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

Review 6.  Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis.

Authors:  V R Patwardhan; A Cardenas
Journal:  Aliment Pharmacol Ther       Date:  2014-06-02       Impact factor: 8.171

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.